Following people with hepatitis B and fatty liver disease over time
Studies how liver disease progresses in people with both hepatitis B and fatty liver.
Plain-language title generated from the registry record
Registry title: Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease
Key facts
- Where
- Hong Kong, ChinaSee the site
Where in China
- Humanity and Health GI and Liver CentreHong Kong, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Humanity and Health Research Centre
- Trial code
- NCT02863757
- Record updated
- 29 July 2026
- Original description
The purpose of this study is to determine the disease progression in CHB/NAFLD compared with CHB and NAFLD including liver cirrhosis, cirrhotic complications and hepatocellular carcinoma (HCC).Read full original descriptionShow less
Disease Progression and Clinical Outcomes in Chronic Hepatitis B (CHB) Patients With Comorbid Nonalcoholic Fatty Liver Disease (NAFLD)
The purpose of this study is to determine the disease progression in CHB/NAFLD compared with CHB and NAFLD including liver cirrhosis, cirrhotic complications and hepatocellular carcinoma (HCC).
Inclusion: Liver biopsy proved CHB and/or NAFLD at baseline; Chinese; Follow-up duration>12 months.
Exclusion: Other liver diseases; Malignancy; History of liver transplantation; Secondary causes of hepatic steatosis; Alcohol abuse; Liver cirrhosis, cirrhosis related complications or HCC at baseline.